1
Morteza Gharib, Hosheng Tu, Olav Bergheim: Bifurcatable trabecular shunt for glaucoma treatment. Glaukos Corporation, Knobbe Martens Olson & Bear, December 23, 2003: US06666841 (171 worldwide citation)

A trabecular shunt and methods for treating glaucoma are disclosed. The method comprises placing a trabecular shunt through diseased trabecular meshwork, between the anterior chamber and Schlemm's canal. The trabecular shunt includes a hollow, elongated tubular element having an inlet section a ...


2
Morteza Gharib, Hosheng Tu, Olav Bergheim: Implant with pressure sensor for glaucoma treatment. Glaukos Corporation, Knobbe Martens Olson & Bear, January 3, 2006: US06981958 (126 worldwide citation)

A trabecular shunt and methods for treating glaucoma are disclosed. One of the methods comprises transporting fluid from the anterior chamber of an eye to Schlemm's canal through an implant, the implant extending between the anterior chamber and Schlemm's canal; sensing an intraocular pressure using ...


3
Hosheng Tu, Olav Bergheim: Medical device having ultrasound imaging and therapeutic means. Hosheng Tu, July 12, 2001: US20010007940-A1

An improved ultrasound device system comprising an ultrasound transducer at about a distal section of an elongate apparatus, wherein the ultrasound transducer comprises the capabilities of ultrasound imaging, RF thermal therapy, cryogenic therapy and temperature sensing for effective treating the ti ...


4
Olav Bergheim, Hosheng Tu, Morteza Gharib: Glaucoma device and methods thereof. Knobbe Martens Olson & Bear, March 27, 2003: US20030060752-A1

A glaucoma treatment device for directing the flow of aqueous humor and reducing intraocular pressure for angle closure glaucoma is disclosed. The glaucoma device comprises an aqueous transporting element for transporting aqueous humor to bypass dysfunctional anatomical iris closure and restoring ex ...


5
Olav Bergheim, Morteza Gharib: Ocular implant with anchor and therapeutic agent. Glaukos Corporation, Knobbe Martens Olson & Bear, September 25, 2008: US20080234624-A2

An ocular disorder treatment implant includes an anchor and a therapeutic agent. The implant has a body with first and second end portions. The implant is configured to transport fluid from the anterior chamber of an eye to a physiological outflow pathway of the eye. The body has at least one inlet ...


6
Morteza Gharib, Hosheng Tu, Olav Bergheim: Bifurcatable trabecular shunt for glaucoma treatment. Knobbe Martens Olson & Bear, November 7, 2002: US20020165478-A1

A trabecular shunt and methods for treating glaucoma are disclosed. The method comprises placing a trabecular shunt through diseased trabecular meshwork, between the anterior chamber and Schlemm's canal. The trabecular shunt includes a hollow, elongated tubular element having an inlet section and an ...


7
Morteza Gharib, Hosheng Tu, Olav Bergheim: Glaucoma implant with extending members. Knobbe Martens Olson & Bear, September 1, 2005: US20050192527-A1

A trabecular shunt and methods for treating glaucoma are disclosed. One of the methods comprises transporting fluid from the anterior chamber of an eye to Schlemm's canal through an implant, the implant extending between the anterior chamber and Schlemm's canal; sensing an intraocular pressure using ...


8
Morteza Gharib, Hosheng Tu, Olav Bergheim: Biodegradable glaucoma implant. Knobbe Martens Olson & Bear, December 29, 2005: US20050288619-A1

A trabecular shunt and methods for treating glaucoma are disclosed. One of the methods comprises transporting fluid from the anterior chamber of an eye to Schlemm's canal through an implant, the implant extending between the anterior chamber and Schlemm's canal; sensing an intraocular pressure using ...


9
Morteza Gharib, Hosheng Tu, Olav Bergheim: Ocular implants with deployable structure. Glaukos Corporation, Knobbe Martens Olson & Bear, March 19, 2009: US20090076436-A2

An implant has a tubular member with an inlet configured to receive fluid from an anterior chamber of an eye, an outlet configured to deliver fluid from the inlet to a physiological outflow pathway of the eye, and a lumen therebetween configured for substantially free flow of the fluid and which gen ...